Roche Holding AG
RO.SW
Get informed when a big investor buys or sells
+ FollowMarket Cap$334.58B
Close$
Share Statistics
| Market cap | $334.58 Billion |
|---|---|
| Enterprise Value | $360.79 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 66.85% |
|---|---|
| Return on Assets | 22.26% |
| Return on Invested Capital | 42.92% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.92 |
| Enterprise Value to EBIT | 12.19 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.97 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Roche Holding AG
103,249 employees
CEO: Severin Schwan Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ...